Value-Based Contracting & Payment
Expert articles and analysis related to value-based contracting & payment.
AI Summary — Last 7 Days
Over the past week, value-based care stakeholders are closely watching CMS’s new ACCESS and LEAD models as pivotal infrastructure opportunities for advancing ACO and population health strategies in Medicare. Recent coverage underscores both the practical promise of these models—such as digital health integration and flexibility in care management—and the operational uncertainties, including critical data gaps and risk-bearing complexities facing 2027 LEAD participants (Wakely analysis). Simultaneously, CMS is proposing a nationwide expansion of the Comprehensive Care for Joint Replacement (CJR) model, signaling continued federal momentum under the Trump administration toward scaling episodic and value-based payment arrangements across broader clinical conditions (CJR expansion coverage). This convergence of new pilot models with legacy expansions
Related Articles
UnitedHealth hikes profit outlook after better-than-expected first quarter
Premium hikes, plan redesigns and other efforts from the Minnesota-based company to wrangle medical spending bore fruit in the first quarter. UnitedHealth’s stock jumped accordingly.
Blue Shield of California taps chief pharmacy officer
Hayley Park will oversee BSCA’s prescription drug programs. The insurer has worked to overhaul its pharmacy management model in a bid to lower drug costs.
Collaborative Learning Opportunity for States Interested in Rural Payment and Delivery Reform
NASHP, Mathematica, and the Rural Health Redesign Center (RHRC) are collaborating on a new project... The post Collaborative Learning Opportunity for States Interested in Rural Payment and Delivery Re...
P3 Health Partners stock (US69375E1055): Why does its value-based care model matter more now for U.S
P3 Health Partners stock (US69375E1055): Why does its value-based care model matter more now for U.S AD HOC NEWS
STAT+: The PBMs fight back, and arbitration doesn’t lose
We unpack the contentious fight over drug price transparency.
Exclusive: Gyde acquires Benavest, marks second deal in two weeks
Gyde, a newly launched AI-enabled brokerage platform focused on insurance, health and wealth, has acquired national health insurance agency Benavest, which specializes in consumer plans such as indivi...
STAT+: PBMs warn Trump’s proposal to disclose drug prices is illegal
Pharma industry middlemen are pushing back on a major drug price transparency proposal.
Value Based Care 2026 How Patient Outcomes Slash Medical Costs by 20 Percent - fakta.co
Value Based Care 2026 How Patient Outcomes Slash Medical Costs by 20 Percent fakta.co
Providence’s physician chief on its ‘holistic’ approach to value-based care
Providence’s physician chief on its ‘holistic’ approach to value-based care Becker's Hospital Review
Improve medication adherence through value-based care
Improve medication adherence through value-based care Aledade